References in periodicals archive ?
Release date- 27082019 - PHILADELPHIA - Spark Therapeutics (NASDAQ: ONCE), a fully-integrated, commercial gene therapy company dedicated to challenging the inevitability of genetic disease, announced today the location of its 2019 Annual Meeting of Stockholders, to be held on Sept.
In addition, the company has said that it will hold its annual meeting of stockholders at 10:00 a.m., local time on November 18, 2019, at the Renaissance Hotel, Asheville, North Carolina.
These restrictions apply until thirty days prior to the deadline for the submission of stockholder nominations for directors at the company's 2021 annual meeting of stockholders.
As a result, the Board will be fully de-classified, with all Directors standing for annual election by the annual meeting of stockholders in 2021.
To implement this change, the 2018 Annual Meeting of Stockholders will be opened on March 6, 2018 at 8:00 a.m.
Also, in connection with this appointment, Violin Memory has entered into an agreement with Clinton Group Inc, an asset management firm, under which the Clinton Group will, among other things, vote its shares in favour of the election of the company's slate of directors at the company's 2014 Annual Meeting of Stockholders. Also, the Clinton Group has agreed to customary standstill provisions.
Swenson's current term as a director will expire at next year's annual meeting of stockholders.
Brandon plans to retire from the board of directors at the annual meeting of stockholders to be held on Oct.
Duherstein as Class I director with a term expiring at the 2007 annual meeting of stockholders.
Under the terms of the settlement, ARV will withdraw its appeal of a May decision in a lawsuit between ARV and Prometheus over Lazard's acquisition of Atria, and Prometheus will dismiss the lawsuit it filed against ARV and two of its former directors regarding the validity of ARV'S annual meeting of stockholders.
The company said it intends to pursue measures to cure the share price non-compliance, including through a reverse stock split of the company's common stock, subject to stockholder approval, no later than at its next annual meeting of stockholders, if such action is necessary to cure the share price non-compliance.
In accordance with NYSE rules, the Company has a period of six months from receipt of the notice to regain compliance with the NYSE's minimum share price requirement, or until the Company's next annual meeting of stockholders if stockholder approval is required to cure the share price non-compliance, as would be the case to effectuate a reverse stock split.

Full browser ?